Cargando…
Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
Background and Objectives: Neuroinflammation is associated with many neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). In this study, we investigate the anti-inflammatory, anti-oxidant, and anti-apoptotic properties of two non-psychoactive phytocannabinoids, cannabigerol (CB...
Autores principales: | Mammana, Santa, Cavalli, Eugenio, Gugliandolo, Agnese, Silvestro, Serena, Pollastro, Federica, Bramanti, Placido, Mazzon, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915685/ https://www.ncbi.nlm.nih.gov/pubmed/31752240 http://dx.doi.org/10.3390/medicina55110747 |
Ejemplares similares
-
In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
por: Gugliandolo, Agnese, et al.
Publicado: (2018) -
The Transcriptomic Analysis of NSC-34 Motor Neuron-Like Cells Reveals That Cannabigerol Influences Synaptic Pathways: A Comparative Study with Cannabidiol
por: Gugliandolo, Agnese, et al.
Publicado: (2020) -
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
por: Silvestro, Serena, et al.
Publicado: (2019) -
Eruca sativa seed extract: A novel natural product able to counteract neuroinflammation
por: Gugliandolo, Agnese, et al.
Publicado: (2018) -
Cannabinoid CB2 Receptors are Involved in the Protection of RAW264.7 Macrophages Against the Oxidative Stress: An in Vitro Study
por: Giacoppo, Sabrina, et al.
Publicado: (2017)